Latest Innovations in Cardiovascular Imaging Software
Published: 15 December 2022
-
Views:
8025
-
Likes:
7
-
Views:
8025
-
Likes:
7
-
20m 45sPart 3 | Session 1 CT Planning for TAVR - Dr Hasan Jilaihawi
-
9m 25sPart 3 | Session 2 CT Planning for TMVR - Dr Torsten Vahl
-
15m 18s
-
10m 21sPart 3 | Session 4 CT Planning for TTVR – Dr Azeem Latib
-
21m 51sPart 3 | Session 5 CT Planning for LAAO - Dr Jens Erik Nielsen Kudsk
-
6m 33sPart 3 | Session 6 CT Planning for TPVR - Dr Xavier Iriart
-
02:12Part 1 | Session 1 Welcome and Introduction Joost Daemen, Kaneshka Masdjedi, Eric Van Belle
-
15:41Part 1 | Session 2 Pressure Wire Measurements and Decision Making in the Cathlab Eric Van Belle
-
15:07Part 1 | Session 3 Role of Angio-derived vFFR and How It Works Kaneshka Masdjedi
-
27:17Part 1 | Session 4 Recorded vFFR Live Case Joost Daemen
-
13:20Part 1 | Session 5 vFFR Validation Pathway – The FAST Series Kaneshka Masdjedi
Overview
Medical Imaging within the cardiovascular arena is constantly subject to changes and new innovations. Pie Medical Imaging (PMI) is a software company that strives to be a front runner in this field.
This page gives an overview of PMI’s latest software developments.

The Key Learnings to Be Taken From the Content Herein Are to Understand:
- The role of medical imaging in interventional cardiology
- What is the added value of medical imaging pre-, peri- and post-percutaneous interventions?
- How does medical imaging blend in the healthcare professional’s daily practice?
This Page Is Designed For:
- Interventional cardiologists
- Cardiac Surgeons
- Radiologists
- Paediatric Cardiovascular Surgeons
More from this programme
Part 1
PCI
Part 2
PCI
Part 3
Structural Heart
Part 4
Structural Heart
Faculty Biographies

Joost Daemen
Interventional cardiologist
Dr Joost Daemen, MD, PhD obtained his degree in medicine at the Erasmus University Medical Center, Rotterdam in 2005 and did 2 years of internal medicine training and 4 years of general cardiology training at the Thoraxcenter, Rotterdam.
Joost is actively involved in several drug-eluting stent trials and is Principal Investigator of 4 trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Joost is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.